REGENERX BIOPHARMACEUTICALS INC | 0,147 Euro | +0,016 +12,21 % | |
| WKN: 875295 ISIN: US75886X1081 Ticker-Symbol: RRX | Frankfurt | 29.08.11 | 10:35 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 09.04. | RegeneRx Receives Four New Patents and Allowances in Mexico and Israel | 33 | Business Wire | |
| RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX)
("the
Company" or "RegeneRx") announced today that the Company has received an
issued patent in Mexico... Mehr lesen zu: RegeneRx Receives Four New Patents and Allowances in Mexico and Israel | ||||
| 04.04. | REGENERX BIOPHARMACEUTICALS INC - 10-K, Annual Report | 1 | SEC Filings | |
| 27.03. | RegeneRx and Lee's Pharmaceutical (HK) Sign Term Sheet for Development of RegeneRx Product Candidates in China, Hong Kong and Macau | 30 | Business Wire | |
| RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) ("the
Company" or "RegeneRx") today announced that it has signed a term sheet
with Lee's Pharmaceutical (HK)... Mehr lesen zu: RegeneRx and Lee's Pharmaceutical (HK) Sign Term Sheet for Development of RegeneRx Product Candidates in China, Hong Kong and Macau | ||||
| 01.02. | RegeneRx Engages Investment Bankers to Assist in Evaluating and Exploring Strategic Opportunities | 37 | Business Wire | |
| RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX)
("the
Company" or "RegeneRx") has hired investment bankers, Ameritech
Advisors, LLC and Aurora Capital... Mehr lesen zu: RegeneRx Engages Investment Bankers to Assist in Evaluating and Exploring Strategic Opportunities | ||||
| 09.01. | RegeneRx Issued Major U.S. Heart Patent | 15 | Business Wire | |
| RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) ("the
Company" or "RegeneRx") today announced that it has been issued a patent
from the U.S. Patent and Trademark... Mehr lesen zu: RegeneRx Issued Major U.S. Heart Patent | ||||
| 05.01. | RegeneRx Receives Clinical Study Report for Phase 2 Dry Eye Trial | 29 | Business Wire | |
| RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) ("the
Company" or "RegeneRx") announced today that it has received the
clinical study report for its recently... Mehr lesen zu: RegeneRx Receives Clinical Study Report for Phase 2 Dry Eye Trial | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| DISCOVERY LABORATORIES INC | 2,033 | -0,68 % | Discovery Laboratories: A Hidden Gem In Biotech |
| CEL-SCI | 0,319 | +3,24 % | CEL-SCI Corporation Releases Letter to Shareholders |
| GENEREX BIOTECHNOLOGY CORPORATION | 0,069 | +2,99 % | Generex Augments Antigen Express Scientific Advisory Board |
| INOVIO PHARMACEUTICALS INC | 0,350 | +7,36 % | Hot Stock: Inovio Biomedical, Shares Gain 12.8% |
| HEMISPHERX BIOPHARMA | 0,166 | -9,78 % | Hemispherx Biopharma FY11 Loss Narrows |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
